Electronic medicines administration record systems are now common across adult social care.
Many providers have transitioned from paper MAR charts to digital platforms in the belief that electronic systems automatically improve safety. In many ways, they do help. They reduce transcription errors, create clearer audit trails and provide better visibility for managers.
However, digital systems do not remove responsibility.
The expectation from the Care Quality Commission is clear. Providers remain accountable for safe care, competent staff, and effective governance. Technology can support those duties, but it cannot replace them.
If your service uses an eMAR system, there are three areas that matter:
How the system is implemented
How the data is reviewed
What happens when the system fails
This article explores what good governance looks like when medicines administration becomes digital. It also links to related Carevia guidance on how strong governance prevents avoidable harm and strengthens inspection readiness.
Why eMAR systems are increasing across the sector
Electronic MAR systems offer real advantages.
They can:
Reduce transcription errors
Provide automatic prompts and alerts
Flag missed or late doses
Allow managers to review administration remotely
Create secure audit trails
Support reporting and analysis
For multi site providers, they offer additional oversight. For single services, they can provide reassurance that medication rounds are visible and traceable.
These are genuine benefits.
But digital does not mean infallible. A well designed system can still be poorly used. A dashboard full of green indicators does not automatically mean practice is safe.
The question is not whether you have an electronic system.
The move from paper to digital does not reduce the requirements under Regulation 12 Safe Care and Treatment or Regulation 17 Good Governance.
You are still responsible for:
Ensuring medicines are administered safely
Ensuring staff are trained and competent
Monitoring errors and near misses
Learning from incidents
Having effective oversight
Maintaining accurate records
An eMAR system is a tool within that framework.
Inspectors will expect to see that you understand how the system works and how you monitor its output. They will expect to see that you do not rely on the software to manage risk on your behalf.
Governance is about what you review, what you question and what you change.
Inspectors will not be impressed by the presence of software alone.
They will explore:
How you monitor performance
How you identify patterns
How you support staff
How you respond to incidents
How you ensure continuity
They may ask staff:
What would you do if the system went down right now?
If staff pause or appear uncertain, that indicates a training gap.
Strong services ensure the answer is immediate and confident.
Leadership and visibility
Electronic systems should not distance leaders from practice.
Instead, they should enhance insight.
Good leaders:
Review reports regularly
Speak to staff about trends
Observe medication rounds periodically
Check stock control processes
Encourage reporting of near misses
Reinforce learning
Digital data should support good oversight, not replace it.
Final reflection
Electronic MAR systems are powerful tools.
They can improve clarity, reduce error and strengthen audit trails.
But safety is created by leadership, not software.
Ask yourself:
If your system stopped working today, would your team continue safely and confidently?
If your answer is yes, your governance is likely well established.
If your answer is uncertain, this is an opportunity to strengthen planning before an inspector asks the question.
Digital systems support safe care.
Clear governance ensures it.
Frequently Asked Questions About eMAR Systems
What does CQC say about electronic MAR systems?
The Care Quality Commission makes clear that electronic medicines administration record systems can support safe care, but they do not replace provider responsibility.
Providers remain accountable for safe administration, competent staff, effective oversight and business continuity planning.
Do electronic MAR systems reduce medication errors?
They can reduce certain risks such as transcription errors and missed signatures. They also improve visibility and audit trails.
However, errors can still occur if alerts are ignored, staff are not trained properly or oversight is weak. Technology supports safe systems, but leadership and governance prevent harm.
Missed medication alerts are often built-in to systems. However, if these are ignored or not acted upon it does not increase safety or governance. This article explains what can happen when medication alerts are not appropriately acted upon Lessons Learned: Medication Management Failures and Avoidable Harm.
What happens if the eMAR system goes down?
Every provider must have a documented downtime procedure.
This should include access to emergency paper MAR templates, clear instructions for recording doses during outages, and a structured reconciliation process when systems are restored.
Staff should be trained in this procedure and able to explain it confidently if asked.
What should managers review each month on an eMAR system?
Managers should review:
Total number of missed doses
Repeated missed doses for one individual
Late administrations
PRN medicine usage and effectiveness
Alert overrides
Medication related incidents
Comparison with the previous month
The most important question is what changed as a result of the review.
Will inspectors expect staff to understand the eMAR system?
Yes. Inspectors may ask staff how they administer medicines using the system, what they would do if an alert appears, and what happens if the system becomes unavailable.
Staff should demonstrate confidence in both routine use and contingency planning.
Is having an eMAR system enough to achieve a Good rating?
No. Inspectors look at how the system is used, how information is reviewed, how incidents are managed and how learning is embedded.
Software alone does not determine inspection outcomes. Governance and leadership do.
